hrp0086fc5.4 | Management of Disorders of Insulin Secretion | ESPE2016
Hoarau Marie
, Fauret Anne-Laure
, Busiah Kanetee
, Godot Cecile
, Colas Sandra
, Treluyer Jean-Marc
, Scharfmann Raphael
, Cave Helene
, Polak Michel
, Beltrand Jacques
Background: Sulfonylureas (SU) have proven to be effective in patients with monogenic diabetes owing to potassium channel mutation. They allow the discontinuation of insulin and a good metabolic control. Long-term data arguing for a persistent beneficial effect of SU are missing.Objective and hypotheses: SU provide a good metabolic control maintained over time in patients with neonatal diabetes.Method: From a French cohort of 34 pa...